Noxopharm Ltd (NOX) — Long-term Investment Intensity
Noxopharm Ltd (NOX) has a Long-term Investment Intensity of 29.6% as of June 2024. Long-term investments of AU$2.01 Million represent 29.6% of total assets of AU$6.78 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Noxopharm Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Noxopharm Ltd Long-term Investment Intensity (2020–2024)
This chart shows how Noxopharm Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2020 to 2024. As of June 2024, the intensity stands at 29.6%, reflecting long-term investments of AU$2.01 Million against total assets of AU$6.78 Million AUD. Explore Noxopharm Ltd (NOX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Noxopharm Ltd (2020–2024)
The table below presents the year-by-year Long-term Investment Intensity for Noxopharm Ltd from 2020 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Noxopharm Ltd worth.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 29.6% | AU$2.01 Million | AU$6.78 Million | ▲ +20.1 pp |
| 2023 | 9.5% | AU$962.05K | AU$10.13 Million | ▼ -10.9 pp |
| 2022 | 20.4% | AU$5.42 Million | AU$26.59 Million | ▼ -9.5 pp |
| 2021 | 29.8% | AU$14.27 Million | AU$47.85 Million | ▼ -2.8 pp |
| 2020 | 32.6% | AU$6.54 Million | AU$20.07 Million | — |